CLINICAL_TRIALS
trial_result
· 2012-06-08
Clinical Trial Update: Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
Summary
Pilot chart review study of sitaxentan in patients with pulmonary arterial hypertension has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED | Results posted: 2012-06-08